ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
•31 Mar 2020 13:10

Celltrion Merger: Potential Controversy from Healthcare's Inventory Situation

Celltrion held the annual general meeting on March 27. During this meeting, CEO Seo reaffirmed the merger between the three siblings. He...

Logo
544 Views
Share
•29 Mar 2020 10:02

Short Sell Ban in Korea: Targeting Block Deal Sell Swap Traders?

Korea's short-selling ban began on March 16. It will be in place for six months until September 15. Of course, market makers and program trading...

Logo
445 Views
Share
•11 Feb 2020 07:18

KOSDAQ150 Rebalance Preview - Stocks Starting to Move

The Korea Exchange (KRX) will announce the results of the June 2020 review of the KOSDAQ 150 index in May. The constituent changes will be...

Logo
693 Views
Share
•29 Jan 2020 17:47

Korea - Pharma Stocks See Short Covering

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 23 January...

Logo
572 Views
Share
•21 Jan 2020 17:51

Korea - Celltrion Shorts Increase, Semco Covering Continues

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 17 January 2020....

Logo
570 Views
Share
x